I picked this up from Twitter - Myositis Support in the USA and Idera are hosting a video chat session about a Phase 2 trial for Idera's drug IMO-8400 for treatment of DM.
Background to the drug and trial is here:
understandingmyositis.org/p...
Registration for the chat session, which will be held on 28th Feb, is here:
understandingmyositis.org/e...
It's not very often that new treatments come along for DM, so should be interesting.
How are the trials hoping for phase 2 of Idera IMO 8400? Interested in hearing all about it.
Thanks
Hi Hopegalore,
Oooh, this was a little while ago now, but thanks for asking.
I did attend this webinar - I think I was the only one from the UK, everyone else was from the USA. It was a really small group, maybe around 5 people with DM (one from the US Myositis Association) plus representatives from Idera. From what I recall, the drug was designed primarily to deal with severe skin symptoms in DM.
A couple of the research scientists explained a bit about how the theory behind how the drug worked and took us through the plans for the phase 2 trials - eligibility, funding, trial centres, protocols etc. I wouldn't have been eligible for the trial on medical grounds, but also, there was no UK trial centre. So though interesting, all this was purely theoretical for me, and I heard nothing more.
I've done some Googling, and found this report from the US Myositis Association:
myositis.org/blog/good-news...
There are other trial reports online if you want further details.
So sadly, it seems that the trial didn't meet its objectives and the drug won't be marketed.
Thanks Lintilla for taking time out to let me know how the proposed trial day unfolded. Truly Appreciated.
Let's hope one day that they will have a worldwide cure for Dermtomyositis and other diseases in the world.
Thanks Again.
Hope life is going well for you.
Hopegalore20 x
